First Header Logo Second Header Logo

Connection

Nicholas Pajewski to Angiogenesis Inhibitors

Back to Details
This is a "connection" page, showing publications Nicholas Pajewski has written about Angiogenesis Inhibitors.
Nicholas Pajewski
Connection Strength
0.148
Angiogenesis Inhibitors
  1. Gower EW, Stein JD, Shekhawat NS, Mikkilineni S, Blachley TS, Pajewski NM. Geographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States. Am J Ophthalmol. 2017 Dec; 184:157-166.
    View in: PubMed
    Score: 0.148
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.